Call us : USA : 1-631-381-2994; Europe : 44-207-097-1828
Mail us : info@creative-biolabs.com
Creative Biolabs Blog

Menu

Skip to content
  • Drug Discovery Research
  • Immunotherapy Research
  • Antibody Engineering Research

What Are the Development Prospects & Anticancer Potential of CD38 Antibodies?

What Are the Development Prospects & Anticancer Potential of CD38 Antibodies?

August 23, 2020Drug Discovery Research, Immunotherapy Researchimmunotherapy, monoclonal antibody, Therapeutic Antibodybiolabs

CD38 protein, which was discovered in 1980, is a type II transmembrane glycoprotein with a size of 46 kDa. The ligand of CD38 is CD31, also known as PECAM-1, which is aRead More…

Cell: Isolated Strong SARS-CoV-2 Neutralizing Antibody from Patients with COVID-19

July 13, 2020Drug Discovery Research, NewsAntibody Discovery, COVID-19biolabs

An important line of defense against novel coronavirus SARS-CoV-2 is the formation of neutralizing antibodies. These antibodies can eliminate invaders and have great potential in the prevention and treatment of SARS-CoV-2 infection.Read More…

Nature: Major Discovery! A Human Antibody Can Strongly Neutralize A Variety of Coronaviruses, including SARS-CoV and SARS-CoV-2

June 2, 2020Drug Discovery Research, Immunotherapy ResearchAntibody Discovery, COVID-19, SARS-CoV-2biolabs

In a new study, researchers from Humabs Biomed SA and the University of Washington found that an antibody that suppresses the associated coronavirus was identified for the first time in a bloodRead More…

Big News! Microbes Control the Health of the Immune System!

May 14, 2020Biological Knowledge, Immunotherapy Research, NewsConventional Dendriticcells, Immune System, immunotherapybiolabs

Researchers from Charité-Universitätsmedizin Berlin, Berlin Institute of Health and Deutsches Rheuma-Forschungszentrum, together with other scientists, have shown how microbes help the immune system respond to pathogens. Without the relevant mediators, the metabolicRead More…

Science: COVID-19 May Relapse Seasonally and the High Temperature in Summer will not Make It Die

April 26, 2020Biological Knowledgebiolabs

Researchers at Harvard University studied the common cold for clues to how the COVID-19 virus might behave. They used close relatives of SARS-CoV-2 to simulate its behavior in the coming months. TheRead More…

National Institutes of Health (NIH) Has Launched a Clinical Trial of Remdesivir in the Treatment of COVID-19

March 17, 2020NewsCOVID-19, virusbiolabs

Nebraska is conducting the first clinical trial of possible coronavirus treatment, which is expected to eventually include 400 patients in 50 locations around the world, officials said. In this international study, halfRead More…

Summary of New Drugs with Clinical Trial Progress Approved by FDA in 2019

January 15, 2020Drug Discovery Research, NewsAntibiotics, Diagnostic Reagents, New Drugs, Targeted Drugsbiolabs

Innovation drives progress. Center for Drug Evaluation and Research (CDER) of FDA has been a strong supporter of innovation in the development of new drugs and biotherapy products. By understanding the mechanismRead More…

Breakthrough! Scientists Have Successfully Reprogrammed T Cells to Improve the Efficacy of Cancer Immunotherapy

December 18, 2019Immunotherapy Researchcell therapy, immunotherapy, T cellbiolabs

In a study published in Nature, scientists from St. Jude’s Children’s Research Hospital and other institutions have developed a new treatment strategy to effectively enhance cancer immunotherapy, which may effectively slow tumorRead More…

A New Antibody is Expected to be Developed as a General Influenza Vaccine

November 7, 2019Drug Discovery ResearchAntibody Discovery, Therapeutic Antibody, virusbiolabs

A team of researchers from the United States have found that an antibody that “embeds” influenza virus surface proteins can protect mice from a variety of influenza virus strains and is expectedRead More…

Comprehensive Analysis of Targeted Drugs for Lung Cancer

October 11, 2019Drug Discovery Research, Immunotherapy Research, Newsimmunotherapy, monoclonal antibody, Small molecule targeted drugsbiolabs

Incidence of lung cancer Lung cancer has the highest incidence of cancer in the world. According to WHO’ statistics, there are an estimated 18.1 million new cancer patients worldwide in 2018, ofRead More…

Posts navigation

  • « Previous
  • 1
  • 2
  • 3
  • 4
  • …
  • 15
  • Next »

Categories

  • Antibody Engineering Research
  • Biological Knowledge
  • Drug Discovery Research
  • Immunotherapy Research
  • News

Recent Posts

  • CD47-related Signaling Pathways & Research Progress on the Relationship with Related Diseases (Part Three)
  • CD47-related Signaling Pathways & Research Progress on the Relationship with Related Diseases (Part Two)
  • CD47-related Signaling Pathways & Research Progress on the Relationship with Related Diseases (Part One)
  • Sci Rep: Monoclonal Antibody can Effectively Treat Malaria
  • Multivalent Single Domain Antibodies Help Block SARS-CoV-2 Infection and Suppress Mutational Escape

Archives

Contact Us

Address: USA – UK – Germany
Tel (USA): 1-631-381-2994
Tel (Europe): 44-207-097-1828
Fax: 1-631-207-8356
Email: info@creative-biolabs.com

Copyright © Creative Biolabs Blog
Powered by WordPress , Designed and Developed by templatesnext